In this downloadable slideset from the CCO Squamous NSCLC live meeting series, Edward S. Kim, MD, and Mark A. Socinski, MD, highlight recent data informing the optimal care of patients with advanced squamous NSCLC.
Expert faculty from the 2017-2018 CCO Local Live meeting series, “Expert Strategies to Optimize the Treatment of Patients With Squamous NSCLC,” answer frequently asked questions about treating squamous NSCLC, including considerations for newly diagnosed disease in special populations, choice of second-line immunotherapy, and management of immune-related adverse events.
Expert faculty from the 2017-2018 CCO Local Live meeting series “Expert Strategies to Optimize the Treatment of Patients With Squamous NSCLC” answer frequently asked questions about treating squamous NSCLC, including considerations regarding tumor mutational burden, optimal sequencing of therapy, and future directions.
In this on-demand Webcast from the 2017 CCO squamous NSCLC live meeting series, Paul K. Paik, MD, provides expert perspective on the optimal treatment of patients with advanced squamous NSCLC including discussion of the most recent clinical data and emerging therapeutic strategies.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.